-300x43.png "Biomed Pharmacy"){kind=small}
puff-500x500.jpg "Protide (25 mcg+250 mcg)/puff")
This is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
